secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0000805928-25-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen reports Q4 2024 revenue $49.4M (+15.1% YoY); FY 2024 revenue $187.3M (+17.8%)
--------------------------------------------------------------------------------

- Q4 2024 revenue expected $49.4M, up 15.1% YoY; full-year 2024 revenue $187.3M, up 17.8%.
- Full-year gross margin expected above 75.5%; cash and investments $39.5M, up $2.5M from 2023.
- Growth driven by commercial execution in Extremities, OMF-Head & Neck, and Resensation adoption.
- Investor Day scheduled for March 4, 2025 to discuss strategic priorities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592825000006/0000805928-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592825000006/axgn-20250110.htm
  HTML page:      https://secwatch.observer/filing/0000805928-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer